London
4 °C
Manchester
4 °C
Glasgow
-7 °C
Dublin
6 °C
Belfast
Washington
Denver
Atlanta
Dallas
22 °C
Houston Texas
New Orleans
El Paso
Phoenix
Los Angeles
18 °C
13 °C
-30 °C
17 °C
20 °C
24 °C
Featured
Last news
Two killed as major quake strikes southern Philippines
A powerful magnitude-7.4 earthquake struck off the southern Philippines on Friday, leaving at least two people dead and triggering regional tsunami warnings that were later lifted.
One killed as major quake strikes southern Philippines
A powerful magnitude-7.4 earthquake struck off the southern Philippines on Friday, killing at least one person and triggering regional tsunami warnings that were later lifted.
Major quake strikes off southern Philippines
A powerful magnitude-7.4 earthquake struck off the southern Philippines on Friday, triggering tsunami warnings in the Asian nation as well as neighbouring Indonesia and Palau.
Forte Group Announces Equity Incentive Grants and Warrant Amendments
VANCOUVER, BC / ACCESS Newswire / October 10, 2025 / Forte Group Holdings Inc. (CSE:FGH)(OTC:FGHFF)(FSE:7BC0, WKN:A40L1Z)("Forte Group" or the "Company"), a next-generation beverage and nutraceutical company focused on longevity and human performance, announces that it has granted stock options ("Stock Options") and restricted share units ("RSUs") to certain directors, officers, and consultants of the Company, effective October 10, 2025 (the "Grant Date"), in accordance with its Omnibus Equity Incentive Plan (OEIP) dated January 4, 2024 (the "Plan").
TripGift(R) Unlocks Glocal Bucket List' Dreams With Launch of New Destination Gift Card SKUs and Marketplaces for Cities, Destinations and Experiences
Travel Commerce Innovation Winner delivers New York, Los Angeles, Miami, London, Paris, Dubai, Tokyo Destination Marketplaces and Bucket List Experience Packages in 103 currencies.
Michelin Guide gets an appetite beyond restaurants
France's famed Michelin Guide, a reference for fine dining for more than a century, is expanding into hotel and wine recommendations as it aims to become a global lifestyle brand.
BioNxt Solutions Provides Update To Annual General Meeting Matters Due To Canadian Postal Strike And IR Activities
VANCOUVER, BC, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) wishes to advise its shareholders, due to the Canada Post mail strike, of alternative ways to vote their shares for the upcoming annual general meeting of shareholders of the Company (the "Meeting").
Zoglo's Announces $80,850 Private Placement of Units
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
Pawsible Ventures Launches $10M Fund and Venture Studio to Build the Next Generation of Animal Wellness Companies
Backed by Victory Square, Pawsible combines capital, incubation, and distribution to accelerate diagnostics, AI, insurance, and wellness innovation in the $250B+ global pet economy.
Bausch Health Announces Results of Special Meeting of Shareholders
LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2025 (the "Shareholders Meeting"). At the Shareholders Meeting, shareholders of the Company approved the ratification, confirmation and approval of the adoption of the Company's Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025, as amended and restated on August 25, 2025 (the "Rights Plan Agreement"), as described in detail in the Company's Management Proxy Circular and Proxy Statement dated August 27, 2025.
Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar
Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities
BioNxt Completes "Fast-Track" US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis
VANCOUVER, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, today announced that it has completed a Track One priority patent filing with the U.S. Patent and Trademark Office (USPTO) for its proprietary sublingual thin-film cladribine formulation (BNT23001), designed for the treatment of multiple sclerosis (MS). The Track One patent filing also covers sublingual drug products for the treatment of many other neurological autoimmune diseases, including myasthenia gravis and lupus nephritis.
Suspect in US court months after deadly Los Angeles fire
A man suspected of deliberately causing one of the deadliest fires in US history appeared in court Wednesday charged with sparking a blaze that tore through Los Angeles in January.
Man arrested over deadly January fire in Los Angeles
Authorities investigating one of the deadly fires that tore through Los Angeles in January said Wednesday they had arrested a man they believe deliberately started the blaze.
Gisele Pelicot urges accused rapist to 'take responsibility'
Gisele Pelicot, the Frenchwoman who became a feminist hero in a mass rape trial last year, was thrust into the national spotlight once again Wednesday, telling the one man who still denies raping her he must "take responsibility" for his actions.
Far right harvests votes as climate rules roil rural Spain
Standing by a barn brimming with hundreds of bleating sheep, Jesus del Socorro Cuevas leads the far right's charge against "dictatorial" EU environmental regulation in his corner of rural Spain.
Australia police foil 'kill team' gang hit near daycare centre
Australian police foiled an alleged organised crime hit by a so-called kill team near a Sydney daycare facility, authorities said Wednesday.
Trump unlikely to win Nobel Peace Prize, but who will?
When it comes to this year's Nobel Peace Prize, one thing is almost certain: US President Donald Trump will not win, no matter how much he wants it. But who will?
Two bodies found, two missing after Madrid building collapse
Spanish emergency services have found two bodies buried in the rubble after a building under construction collapsed in central Madrid Tuesday, with two more people still missing and several workers injured, authorities said.
Ecuador president unharmed after apparent gun attack on motorcade
Ecuador's president emerged unharmed from an apparent gun attack on his motorcade Tuesday, a top minister said.
Trump says 'real chance' to end Gaza war as Israel marks attacks anniversary
US President Donald Trump voiced optimism that there was a "real chance" to end the war in Gaza, as Israel remembered victims of the October 7 attacks two years ago on Tuesday.
Is Trump planning something big against Venezuela's Maduro?
Now that the United States claims legal justification for attacking what it says are Venezuelan drug runners in the Caribbean, one hot question is whether something bigger against President Nicolas Maduro is afoot.
Extreme rains hit India's premier Darjeeling tea estates
Torrential rains that triggered deadly landslides and floods in India's Darjeeling region also destroyed swathes of premier tea estates, officials said Tuesday.
Alex Honnold to Lead His First-Ever Travel Series, in Partnership With Travel Nevada and Outside
Get a Little Out There with Alex Honnold will reveal the hidden stories, unexpected contrasts, and perspective-shifting experiences in his home state
RETRANSMISSION UniDoc Announces LIFE Offering
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
ATLANTA, GEORGIA / ACCESS Newswire / October 7, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company developing new medicines to treat pain, today announced that its Chief Medical Officer will present an overview of the Halneuron®(tetrodotoxin) pain management research program at the 19th Annual Pain Therapeutics Summit on October 14, 2025.
AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting
Pilot Evaluation: Toronto Heart Centre to conduct comparative testing of CardioYield™ for enhanced Holter ECG analysis and reporting efficiency.Clinical Workflow Impact: Study to measure time savings, throughput improvements, and analysis quality when using CardioYield™ versus current industry-standard software.
The 7 Virtues Launches Buttercream Haze, The Rebel Gourmand
Brand welcomes new leaders Lori Wachs and Hope Bonneville, grows to 2,100 Sephora doors globally, and debuts its boldest gourmand yet
Trump says may invoke Insurrection Act to deploy more troops in US
President Donald Trump threatened Monday to use emergency powers against rebellion to deploy more troops into Democratic-led US cities, intensifying his rhetoric as his attempts to mobilize the military face legal challenges.
Hamas and Israel open talks in Egypt under Trump's Gaza peace plan
Delegations from Hamas and Israel on Monday began indirect talks in Egypt's Sharm El-Sheikh on ending the nearly two-year war in Gaza, under a plan put forward by US President Donald Trump.
ICC finds Sudan militia chief guilty of crimes against humanity
The International Criminal Court (ICC) on Monday convicted a feared Sudanese militia chief for war crimes and crimes against humanity committed during brutal attacks in Darfur.
One hiker dead, hundreds rescued after heavy snowfall in China
One hiker died and hundreds of others were rescued after sudden heavy snowfall on the Tibetan Plateau and near Mount Everest on the Chinese side, state media and hikers reported on Monday.